UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 1
(Mark One)
x |
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2007
or
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 000-50797
MOMENTA PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
04-3561634 |
(State or other jurisdiction of |
|
(I.R.S. Employer Identification No.) |
675 West Kendall Street, Cambridge, Massachusetts 02142
(Address of principal executive offices) (zip code)
Registrants telephone number, including area code: (617) 491-9700
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value |
|
NASDAQ Global Market |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o |
Accelerated filer x |
Non-accelerated filer o |
Smaller reporting |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The aggregate market value of the registrants voting shares of Common Stock held by non-affiliates of the registrant on June 29, 2007, based on $10.08 per share, the last reported sale price of the shares of Common Stock on the Nasdaq Global Market on that date, was $216,699,235.
The number of shares outstanding of each of the registrants classes of common stock, as of February 29, 2008:
Class |
|
Number of Shares |
Common Stock, $0.0001 par value |
|
36,759,169 |
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of the information required by Part III of Form 10-K will appear in the registrants definitive Proxy Statement on Schedule 14A for the 2008 Annual Meeting of Stockholders and are hereby incorporated by reference into this report.
EXPLANATORY NOTE
Momenta Pharmaceuticals, Inc. is filing this Amendment No. 1 to its Annual Report on Form 10-K for the year ended December 31, 2007, as originally filed with the SEC on March 10, 2008, for the purpose of correcting a typographical error in Exhibit 23.1 and amending and restating the Exhibit Index. The Exhibit Index is also being amended to add new officer certifications in accordance with Rule 13a-14(a) of the Exchange Act. This Amendment No. 1 on Form 10-K/A does not change the previously reported financial statements or any of the other disclosure contained in the original Form 10-K.
PART IV
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following documents are included as part of this Annual Report on Form 10-K.
1. Financial Statements:
2. All schedules are omitted as the information required is either inapplicable or is presented in the financial statements and/or the related notes.
3. The Exhibits listed in the Exhibit Index immediately preceding the Exhibits are filed as a part of this Annual Report on Form 10-K.
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 14th day of November, 2008.
|
Momenta Pharmaceuticals, Inc. |
|
|
|
|
|
By: |
/s/ CRAIG A. WHEELER |
|
|
Craig A. Wheeler |
|
|
Chief Executive Officer |
2
EXHIBIT INDEX
|
|
|
|
|
|
Incorporated by Reference to |
||||
Exhibit |
|
Description |
|
Form or |
|
Exhibit |
|
Filing |
|
SEC File |
|
|
Articles of Incorporation and By-Laws |
|
|
|
|
|
|
|
|
3.1 |
|
Third Amended and Restated Certificate of Incorporation |
|
S-1 |
|
3.3 |
|
3/11/2004 |
|
333-113522 |
3.2 |
|
Certificate of Designations of Series A Junior Participating Preferred Stock of the Registrant |
|
8-K |
|
3.1 |
|
11/8/2005 |
|
000-50797 |
3.3 |
|
Second Amended and Restated By-Laws |
|
S-1 |
|
3.4 |
|
3/11/2004 |
|
333-113522 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Instruments Defining the Rights of Security Holders |
|
|
|
|
|
|
|
|
4.1 |
|
Specimen Certificate evidencing shares of common stock |
|
S-1/A |
|
4.1 |
|
6/15/2004 |
|
333-113522 |
4.2 |
|
Second Amended and Restated Investors Rights Agreement, dated as of February 27, 2004, by and among the Purchasers listed therein, the Founders listed therein and the Registrant; Amendment No. 1 to Second Amended and Restated Investors Rights Agreement dated June 10, 2004, by and among the Registrant and the Investors set forth therein |
|
S-1/A |
|
4.3 |
|
6/15/2004 |
|
333-113522 |
4.3 |
|
Rights Agreement, dated as of November 7, 2005, between American Stock Transfer & Trust Company, as Rights Agent, and the Registrant |
|
8-K |
|
4.1 |
|
11/8/2005 |
|
000-50797 |
4.4 |
|
Investor Rights Agreement, dated as of July 25, 2006, by and between Novartis Pharma AG and the Registrant |
|
10-Q |
|
10.2 |
|
11/8/2006 |
|
000-50797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Material ContractsLicense Agreements |
|
|
|
|
|
|
|
|
10.1 |
|
Collaboration and License Agreement, dated November 1, 2003, by and among Biochemie West Indies, N.V., Geneva Pharmaceuticals, Inc. and the Registrant |
|
S-1/A |
|
10.4 |
|
5/11/2004 |
|
333-113522 |
10.2 |
|
Amended and Restated Exclusive Patent License Agreement, dated November 1, 2002, by and between the Massachusetts Institute of Technology and the Registrant (the November 1, 2002 M.I.T. License); First Amendment to the November 1, 2002 M.I.T. License, dated November 15, 2002, by and between the Massachusetts Institute of Technology and the Registrant; Letter Agreement, dated September 12, 2003, between the Massachusetts Institute of Technology and the Registrant; Letter Agreement, dated October 22, 2003, between the Massachusetts Institute of Technology and the Registrant; Second Amendment to the November 1, 2002 M.I.T. License, dated November 19, 2003, by and between the Massachusetts Institute of Technology and the Registrant; Third Amendment to the November 1, 2002 M.I.T. License, dated April 2, 2004, by and between the Massachusetts Institute of Technology and the Registrant |
|
8-K |
|
10.1 |
|
8/15/2006 |
|
000-50797 |
10.3 |
|
Letter Agreement Regarding November 1, 2002 M.I.T. License, dated August 4, 2006, between the Massachusetts Institute of Technology and the Registrant |
|
8-K |
|
10.1 |
|
8/15/2006 |
|
000-50797 |
3
10.4 |
|
Letter Agreement Regarding November 1, 2002 M.I.T. License, dated October 18, 2006, between the Massachusetts Institute of Technology and the Registrant |
|
10-Q |
|
10.6 |
|
11/8/2006 |
|
000-50797 |
10.5 |
|
Exclusive Patent License Agreement, dated October 31, 2002, by and between the Massachusetts Institute of Technology and the Registrant (the October 31, 2002 M.I.T. License); First Amendment to the October 31, 2002 M.I.T. License, dated November 15, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
S-1/A |
|
10.6 |
|
5/11/2004 |
|
333-113522 |
10.6 |
|
Fourth Amendment to the Amended and Restated Exclusive Patent License Agreement, dated November 1, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
10-Q |
|
10.3 |
|
8/16/2004 |
|
000-50797 |
10.7 |
|
Fifth Amendment to the Amended and Restated Exclusive Patent License Agreement, dated November 1, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
10-Q |
|
10.5 |
|
11/8/2006 |
|
000-50797 |
10.8 |
|
Sixth Amendment to the Amended and Restated Exclusive Patent License Agreement, dated November 1, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
10-K |
|
10.8 |
|
3/15/2007 |
|
000-50797 |
10.9 |
|
Second Amendment to the Exclusive Patent License Agreement, dated October 31, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
10-Q |
|
10.4 |
|
8/16/2004 |
|
000-50797 |
10.10 |
|
Third Amendment to the Exclusive Patent License Agreement, dated October 31, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
10-Q |
|
10.4 |
|
11/8/2006 |
|
000-50797 |
10.11 |
|
Fourth Amendment to the Exclusive Patent License Agreement, dated October 31, 2002, by and between the Massachusetts Institute of Technology and the Registrant |
|
10-K |
|
10.11 |
|
3/15/2007 |
|
000-50797 |
10.12 |
|
Collaboration and License Agreement, dated June 13, 2007, by and between Sandoz AG and the Registrant |
|
10-Q |
|
10.1 |
|
8/9/2007 |
|
000-50797 |
10.13 |
|
Letter Agreement dated January 29, 2007 between Sandoz AG and the Registrant |
|
10-K |
|
10.16 |
|
3/15/2007 |
|
000-50797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Material ContractsManagement Contracts and Compensation Plans |
|
|
|
|
|
|
|
|
10.14# |
|
Amended and Restated 2002 Stock Incentive Plan |
|
10-K |
|
10.17 |
|
3/15/2007 |
|
000-50797 |
10.15# |
|
2004 Stock Incentive Plan, as amended |
|
10-K |
|
10.18 |
|
3/15/2007 |
|
000-50797 |
10.16# |
|
Form of Incentive Stock Option Agreement Granted Under 2004 Stock Incentive Plan |
|
10-Q |
|
10.1 |
|
8/16/2004 |
|
000-50797 |
10.17# |
|
Form of Nonstatutory Stock Option Agreement Granted Under 2004 Stock Incentive Plan |
|
10-Q |
|
10.2 |
|
8/16/2004 |
|
000-50797 |
10.18# |
|
Form of Restricted Stock Agreement under 2004 Stock Incentive Plan |
|
8-K |
|
10.2 |
|
2/28/08 |
|
000-50797 |
10.19# |
|
2004 Employee Stock Purchase Plan |
|
S-1/A |
|
10.3 |
|
4/16/2004 |
|
333-113522 |
10.20# |
|
Executive Officer Compensation Summary |
|
10-K |
|
10.20 |
|
3/10/2008 |
|
000-50797 |
4
10.21# |
|
Non-Employee Director Compensation Summary |
|
10-K |
|
10.21 |
|
3/10/2008 |
|
000-50797 |
10.22# |
|
First Amended and Restated Employment Agreement, dated April 10, 2002, by and between Ganesh Venkataraman and the Registrant |
|
S-1 |
|
10.12 |
|
3/11/2004 |
|
333-113522 |
10.23# |
|
Restricted Stock Purchase Agreement, dated June 13, 2001, by and between Ganesh Venkataraman and the Registrant |
|
S-1 |
|
10.13 |
|
3/11/2004 |
|
333-113522 |
10.24# |
|
Reallocation of Founder Shares Agreement, dated April 10, 2002, by and among Ganesh Venkataraman, Ram Sasisekharan, Robert S. Langer, Jr., Polaris Venture Partners III, L.P. and the Registrant |
|
S-1 |
|
10.14 |
|
3/11/2004 |
|
333-113522 |
10.25# |
|
Restricted Stock Agreement, dated March 7, 2006, between Ganesh Venkataraman and the Registrant |
|
10-Q |
|
10.14 |
|
11/8/2006 |
|
000-50797 |
10.26# |
|
Restricted Stock Purchase Agreement, dated June 13, 2001, by and between Robert S. Langer, Jr. and the Registrant |
|
S-1 |
|
10.18 |
|
3/11/2004 |
|
333-113522 |
10.27# |
|
Restricted Stock Purchase Agreement, dated June 13, 2001, by and between Ram Sasisekharan and the Registrant |
|
S-1 |
|
10.20 |
|
3/11/2004 |
|
333-113522 |
10.28# |
|
Restricted Stock Purchase Agreement, dated June 13, 2001, by and between Peter Barton Hutt and the Registrant |
|
S-1 |
|
10.22 |
|
3/11/2004 |
|
333-113522 |
10.29# |
|
Employment Agreement, dated August 22, 2006, between Craig Wheeler and the Registrant |
|
10-Q |
|
10.7 |
|
11/8/2006 |
|
000-50797 |
10.30# |
|
Restricted Stock Agreement, dated August 22, 2006, between Craig Wheeler and the Registrant |
|
10-Q |
|
10.8 |
|
11/8/2006 |
|
000-50797 |
10.31# |
|
Nonstatutory Stock Option Agreement, dated August 22, 2006, between Craig Wheeler and the Registrant |
|
10-Q |
|
10.9 |
|
11/8/2006 |
|
000-50797 |
10.32# |
|
Incentive Stock Option Agreement, dated August 22, 2006, between Craig Wheeler and the Registrant |
|
10-Q |
|
10.10 |
|
11/8/2006 |
|
000-50797 |
10.33# |
|
Restricted Stock Agreement, dated March 7, 2006, between Steven B. Brugger and the Registrant |
|
10-Q |
|
10.13 |
|
11/8/2006 |
|
000-50797 |
10.34# |
|
Restricted Stock Agreement, dated December 15, 2006, between John E. Bishop and the Registrant |
|
10-K |
|
10.56 |
|
3/15/2007 |
|
000-50797 |
10.35# |
|
Restricted Stock Agreement, dated December 14, 2007, between John E. Bishop and the Registrant |
|
10-K |
|
10.35 |
|
3/10/2008 |
|
000-50797 |
10.36# |
|
Restricted Stock Agreement, dated August 15, 2007, between Richard P. Shea and the Registrant |
|
10-Q |
|
10.1 |
|
11/08/2007 |
|
000-50797 |
10.37# |
|
Restricted Stock Agreement, dated January 17, 2007, between Craig Wheeler and the Registrant |
|
10-Q |
|
10.7 |
|
11/8/2006 |
|
000-50797 |
10.38# |
|
Form of Executive Retention Agreement between the Registrant and each of John E. Bishop, Steven B. Brugger, Richard P. Shea and Ganesh Venkataraman |
|
10-K |
|
10.57 |
|
3/15/2007 |
|
000-50797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Material ContractsCredit Agreements |
|
|
|
|
|
|
|
|
10.39 |
|
Loan and Security Agreement, dated December 27, 2002, by and between Silicon Valley Bank and the Registrant |
|
S-1 |
|
10.23 |
|
3/11/2004 |
|
333-113522 |
10.40 |
|
First Loan Modification Agreement, dated December 28, 2004, between Silicon Valley Bank and the Registrant |
|
10-K |
|
10.37 |
|
3/31/2005 |
|
000-50797 |
10.41 |
|
Loan and Security Agreement, dated December 28, 2004, between Silicon Valley Bank and the Registrant |
|
10-K |
|
10.38 |
|
3/31/2005 |
|
000-50797 |
10.42 |
|
Master Lease Agreement, dated December 30, 2005, between General Electric Capital Corporation and the Registrant |
|
10-K |
|
10.44 |
|
3/16/2006 |
|
000-50797 |
5
|
|
Material ContractsLeases |
|
|
|
|
|
|
|
|
10.43 |
|
Sublease Agreement, dated September 14, 2004, by and between Vertex Pharmaceuticals Incorporated and the Registrant |
|
10-Q |
|
10.9 |
|
11/12/2004 |
|
000-50797 |
10.44 |
|
First Amendment to Sublease (regarding Sublease Agreement, dated September 14, 2004), dated September 7, 2005, between Vertex Pharmaceuticals Incorporated and the Registrant |
|
10-Q |
|
10.3 |
|
11/14/2005 |
|
000-50797 |
10.45 |
|
Second Amendment to Sublease (regarding Sublease Agreement, dated September 14, 2004, as amended), effective as of November 21, 2005, between Vertex Pharmaceuticals Incorporated and the Registrant |
|
10-K |
|
10.47 |
|
3/16/2006 |
|
000-50797 |
10.46 |
|
Third Amendment to Sublease (regarding Sublease Agreement, dated September 14, 2004, as amended), effective as of January 27, 2006, between Vertex Pharmaceuticals Incorporated and the Registrant |
|
10-K |
|
10.48 |
|
3/16/2006 |
|
000-50797 |
10.47 |
|
Letter Agreement (regarding Sublease Agreement, dated September 14, 2004, as amended), dated June 29, 2006, between Vertex Pharmaceuticals Incorporated and the Registrant |
|
10-Q |
|
10.01 |
|
8/9/2006 |
|
000-50797 |
10.48 |
|
Purchase Agreement, dated October 31, 2007, between Alnylam Pharmaceuticals, Inc. and the Registrant |
|
10-Q |
|
10.2 |
|
11/8/2007 |
|
000-50797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Material ContractsPurchase Agreements |
|
|
|
|
|
|
|
|
10.49 |
|
Stock Purchase Agreement, dated July 25, 2006, by and between Novartis Pharma AG and the Registrant |
|
10-Q |
|
10.1 |
|
11/8/2006 |
|
000-50797 |
10.50 |
|
Asset Purchase Agreement between the Registrant, Parivid LLC and S. Raguram dated April 20, 2007. |
|
10-Q |
|
10.3 |
|
5/10/2007 |
|
000-50797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional Exhibits |
|
|
|
|
|
|
|
|
21 |
|
List of Subsidiaries |
|
10-K |
|
21 |
|
3/10/2008 |
|
000-50797 |
*23.1 |
|
Consent of Independent Registered Public Accounting Firm |
|
|
|
|
|
|
|
|
31.1 |
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14 or 15d-14, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002 |
|
10-K |
|
31.1 |
|
3/10/2008 |
|
000-50797 |
31.2 |
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14 or 15d-14, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002 |
|
10-K |
|
31.2 |
|
3/10/2008 |
|
000-50797 |
*31.3 |
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14 or 15d-14, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
|
|
|
*31.4 |
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14 or 15d-14, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
|
|
|
32.1 |
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Exchange Act Rules 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002 |
|
10-K |
|
32.1 |
|
3/10/2008 |
|
000-50797 |
* Filed herewith.
Confidential treatment requested as to certain portions, which portions are omitted and filed separately with the Securities and Exchange Commission.
# Management contract or compensatory plan or arrangement filed as an Exhibit to this report pursuant to 15(a) and 15(c) of Form 10-K.
6